Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
about
Second-generation antipsychotics and extrapyramidal adverse effectsSchizophreniaCognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigorAre psychiatrists an endangered species? Observations on internal and external challenges to the professionHaloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersBifeprunox versus placebo for schizophreniaFluphenazine decanoate (depot) and enanthate for schizophreniaPerphenazine versus low-potency first-generation antipsychotic drugs for schizophreniaFlupenthixol versus low-potency first-generation antipsychotic drugs for schizophreniaFluphenazine versus low-potency first-generation antipsychotic drugs for schizophreniaHaloperidol versus low-potency first-generation antipsychotic drugs for schizophreniaTrifluoperazine versus low-potency first-generation antipsychotic drugs for schizophreniaHaloperidol versus first generation antipsychotics for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaQuetiapine versus other atypical antipsychotics for schizophreniaFluphenazine (oral) versus atypical antipsychotics for schizophreniaQuetiapine versus typical antipsychotic medications for schizophreniaLevomepromazine for schizophreniaZotepine versus other atypical antipsychotics for schizophreniaRisperidone versus other atypical antipsychotics for schizophreniaFlupenthixol versus low-potency first generation antipsychotic drugs for schizophreniaFluphenazine versus low-potency first generation antipsychotic drugs for schizophreniaHaloperidol versus low-potency first-generation antipsychotic drugs for schizophreniaAsenapine versus other atypical antipsychotics for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaPerphenazine versus low-potency first generation antipsychotic drugs for schizophreniaTrifluoperazine versus low-potency first generation antipsychotic drugs for schizophreniaAntipsychotic medication for early episode schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaZiprasidone versus other atypical antipsychotics for schizophreniaAmisulpride versus other atypical antipsychotics for schizophreniaLevomepromazine for schizophreniaZotepine versus other atypical antipsychotics for schizophreniaQuetiapine versus typical antipsychotic medications for schizophreniaQuetiapine versus other atypical antipsychotics for schizophreniaRisperidone versus placebo for schizophreniaSertindole versus other atypical antipsychotics for schizophreniaLoxapine for schizophreniaZiprasidone versus other atypical antipsychotics for schizophrenia
P2860
Q21284676-C30BAFD1-C803-4E26-9F26-8D58D9332756Q22242092-F2975365-1F6D-40D6-A0FD-C0BECD3ACBE5Q22242831-FBDC61D2-CB8A-44DD-9BF2-EA7DAD02BC6AQ22252897-EC5C0B44-7A1F-418F-9790-F2E7764DB2E5Q24186601-6FF864EF-3764-46D6-A7ED-BCA8DF8D2F60Q24186774-F4711022-3B83-406E-A5FA-6C3FDAF7E0A5Q24188205-EDC884A2-8E3F-488A-A4EA-FDE30686126AQ24193168-A6809D93-5F88-47D6-918C-E099EF2EB670Q24193881-39134ED8-301F-45AC-88AC-FC2AB2A1C0F0Q24194501-129372C3-EC49-45E7-BB00-0734914BE34FQ24194891-27DDC106-BA65-4D1D-A9F1-97A2852F9986Q24194898-39B01918-7405-4321-B642-BBE670D47E5EQ24198264-B803C9D0-17B4-41C6-B4CA-DD09BFFB06A3Q24200904-A2F46FE3-2B25-4E02-BBC9-FC4891C78CAFQ24201232-1B70D1D1-04EA-487E-809A-0599892C5392Q24202427-81217458-835F-43BF-9B37-89050C936BF6Q24202712-46D2AD0D-C2CA-4856-B4EE-999A078DF9D8Q24202829-F3326064-9CC6-42DA-89EC-F53CB027FF05Q24234510-750B9F0A-DF89-4F56-A84B-3595047CB130Q24234683-013D10CA-8471-4B5F-9BDD-AA43B2B9C16BQ24234950-7B2917D7-F2D4-4580-A7E8-A9E6FFD1D91CQ24235116-00C9082D-76A8-43B3-AD1C-D6F098423E2CQ24235274-EF69BCDC-FA12-48EB-A7EB-0CB9562871A9Q24235300-4FF2ACF6-5297-401B-BC75-2FD7554ACCA7Q24236055-874E1692-2F87-4F9E-9483-94D3EEF26B17Q24236545-418BD22D-242B-4019-8EC3-5093F782648EQ24236586-A13D7F43-49A9-44D2-A358-3CB63D5741C8Q24236681-22A7D5BF-08AE-48B1-BC2D-34196946053EQ24236683-E818D7DD-888B-4D2D-BCC1-689A819067EDQ24240020-013B2764-E4AC-4E0F-8A2C-D6EDA3647AB5Q24240260-C8158A3B-12F1-4BA3-A1AF-DD17B9894FA3Q24240433-3B1C4C68-DE25-4B11-91CA-2753E71BB52AQ24240443-44A6BB5E-5ADE-4FAA-81BE-07F211295E46Q24240500-9116868F-55B5-4EF2-93EC-F261CDA1D5DAQ24240519-BFEFB587-DD6A-4BC4-8FF9-0D2F5120486FQ24240989-A4C9FF7D-4006-4B95-ABB6-63B2A4CB9594Q24241041-99D550A4-FB11-40D9-85BE-10E67683A253Q24241594-4FCEC352-BC85-463D-9918-F4136CB65D09Q24242896-7B9CC409-4B6B-4735-98BE-05A0C9A9B77DQ24244488-7E7B6C69-45E5-47BE-9FF5-DFFEDCEDEB79
P2860
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Randomized controlled trial of ...... hizophrenia Study (CUtLASS 1).
@ast
Randomized controlled trial of ...... hizophrenia Study (CUtLASS 1).
@en
Randomized controlled trial of ...... c Drugs in Schizophrenia Study
@nl
type
label
Randomized controlled trial of ...... hizophrenia Study (CUtLASS 1).
@ast
Randomized controlled trial of ...... hizophrenia Study (CUtLASS 1).
@en
Randomized controlled trial of ...... c Drugs in Schizophrenia Study
@nl
prefLabel
Randomized controlled trial of ...... hizophrenia Study (CUtLASS 1).
@ast
Randomized controlled trial of ...... hizophrenia Study (CUtLASS 1).
@en
Randomized controlled trial of ...... c Drugs in Schizophrenia Study
@nl
P2093
P50
P1433
P1476
Randomized controlled trial of ...... hizophrenia Study (CUtLASS 1).
@en
P2093
Alison Markwick
Graham Dunn
Helen Lloyd
Karen P Hayhurst
Shôn W Lewis
Thomas R E Barnes
P304
P356
10.1001/ARCHPSYC.63.10.1079
P407
P577
2006-10-01T00:00:00Z